Concordia International Corp.

(CXR:CHI)

By |

Profile

Concordia International is a biotechnology company that manages, acquires, and develops drugs. The company's operations include pharmaceutical products and orphan drugs. The product portfolio includes legacy drugs that have reached full maturity but continue to generate predictable revenue. Concordia focuses on products with a well-established record of safety and efficacy, as well as a history of stable, predictable prescription demand regardless of the stage of the product's life cycle.

Contact Information

Website: www.concordiarx.com
Main Phone: +1 905 842-5150
Address: 277 Lakeshore Road East
Address 2: Suite 302
State: ON
City / Town: Oakville
Country: CAN
Postal Code: L6J 1H9

Issuer Information

Exchange: TSX
CEO: Allan Oberman
Employees: 444
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.69 0.69 0.69 0.69
Low Target Price Estimate 0.69 0.69 0.69 0.69
Mean Target Price Estimate 0.69 0.69 0.69 0.69
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/11/17 05/11/17 05/11/17 05/11/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 5 5 5 5